Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | TSHR | P16473 | 1/20 | 0.58 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.47 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | ELANE | P08246 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Formaldehyde SCHEMBL28509807 | 0.96 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL10645335 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL10645330 | 0.87 | ALDH1A1 (0.56) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL6814027 | 0.86 | TSHR (0.51) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL16805831 | 0.86 | ALDH1A1 (0.51) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL6156217 | 0.86 | TSHR (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL6643657 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL12412848 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL1484984 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 | |
| SCHEMBL10426175 | 0.86 | ALDH1A1 (0.55) | ALDH1A1TSHRTDP1MAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4383945-A | 4-Substituted-2-oxoazetidine compounds and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-05-17 | — | — | US | claimed |
| EP-0073451-A2 | Carbapenam compound and processes for the preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1983-03-09 | — | — | EP | claimed |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | ARYLESSENCE INC (US) | 2026-03-12 | — | — | US | disclosed |
| WO-2023173227-A1 | C4-SUBSTITUTED TRYPTAMINE DERIVATIVES AND METHODS OF USING | Enveric Biosciences Canada Inc. (CA) | 2023-09-21 | — | — | WO | disclosed |
| US-11732093-B2 | Cross polymers composed of polysaccharides and polyamino acids, and uses thereof | POLYPEPTIDE THERAPEUTIC SOLUTIONS S.L. (ES) | 2023-08-22 | — | — | US | disclosed |
| US-20230165843-A1 | USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES | GANNEX PHARMA CO LTD (CN) | 2023-06-01 | — | — | US | disclosed |
| US-9766547-B2 | Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, method of manufacturing electronic device using the same, and electronic device | FUJIFILM CORPORATION (JP) | 2017-09-19 | — | — | US | disclosed |
| US-9760003-B2 | Pattern forming method and actinic-ray- or radiation-sensitive resin composition | FUJIFILM CORPORATION (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9760003-B2 | Pattern forming method and actinic-ray- or radiation-sensitive resin composition | FUJIFILM CORPORATION (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9709892-B2 | Actinic-ray- or radiation-sensitive resin composition and method of forming pattern using the same | FUJIFILM CORPORATION (JP) | 2017-07-18 | — | — | US | disclosed |
| US-9557643-B2 | Pattern forming method, actinic ray-sensitive or radiation-sensitive resin composition, resist film, manufacturing method of electronic device using the same and electronic device | FUJIFILM CORPORATION (JP) | 2017-01-31 | — | — | US | disclosed |
| US-20120282548-A1 | PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM | FUJIFILM CORPORATION (JP) | 2012-11-08 | — | — | US | disclosed |
| EP-0511948-B1 | Preparation of urethane and carbonate products | MONSANTO CO (US) | 1997-11-05 | — | — | EP | disclosed |
| US-5371183-A | Reacting diamine or polyamine with carbon dioxide in solvent in presence of sterically hindered amidine or guanidine to form salt, reacting with hydrocarbyl dihalide or polyhalide in polar aprotic solvent, polymerizing product | MONSANTO COMPANY (US) | 1994-12-06 | — | — | US | disclosed |
| US-5349048-A | Reaction of carbon dioxide with alcohol to form salt in solvent and reacting with hydrocarbyl halide | MONSANTO COMPANY (US) | 1994-09-20 | — | — | US | disclosed |
| US-5344934-A | Reaction of carbon dioxide and amine in aprotic solvents | MONSANTO COMPANY (US) | 1994-09-06 | — | — | US | disclosed |
| US-5260473-A | Reaction of alcohol and carbon dioxide in aprotic solvent and strong amidine or guanidine base | MONSANTO COMPANY (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0556538-A1 | Blocked tricarbamate compounds | MONSANTO COMPANY (US) | 1993-08-25 | — | — | EP | disclosed |
| US-5223638-A | Reacting primary or secondary amine with carbon dioxide in presence of strong amidine or guanidine base to form ammonium carbamate salt, reacting in polar aprotic solvent with primary or secondary hydrocarbyl halide | MONSANTO COMPANY (US) | 1993-06-29 | — | — | US | disclosed |
| EP-0511948-A2 | Preparation of urethane and carbonate products | MONSANTO COMPANY (US) | 1992-11-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230165843-A1 | USE AND PHARMACEUTICAL COMPOSITION OF PHENYLISOXAZOLYL METHYLENE-NAPHTHALENE-ETHER DERIVATIVES | VIM, CYP3A7, HAVCR2 | ALDH1A1 681/4885TSHR 4238/4885TDP1 4496/4885 |
| US-11732093-B2 | Cross polymers composed of polysaccharides and polyamino acids, and uses thereof | CD44, CUTA, PARG | ALDH1A1 2246/4885TSHR 3476/4885TDP1 2738/4885 |
| US-20120282548-A1 | PATTERN FORMING METHOD, ACTINIC RAY-SENSITIVE OR RADIATION-SENSITIVE RESIN COMPOSITION AND RESIST FILM | RAD51, RER1, RXRA | ALDH1A1 2723/4885TSHR 2059/4885TDP1 588/4885 |
| US-20260069734-A1 | FRESHENING COMPOSITIONS COMPRISING CONTROLLED RELEASE MODULATORS | FFAR1, FFAR2, FFAR3 | ALDH1A1 697/4885TSHR 1822/4885TDP1 4632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.